[Skip to Content]
[Skip to Content Landing]

Blue Pigmentation of the Skin, Sclera, and Teeth

Educational Objective
Based on this clinical scenario and the accompanying image, understand how to arrive at a correct diagnosis.
1 Credit CME

A 69-year-old man presented with a 1-month history of progressive skin discoloration. His medical history included chronic kidney disease, chronic hepatitis C infection, cirrhosis, ischemic cardiomyopathy with an implantable cardioverter-defibrillator (ICD), and atrial fibrillation with prophylactic apixaban. He had recurrent staphylococcus bacteremia due to infection of an ICD lead and had been treated for the past 6 months with minocycline, 100 mg twice daily. His arms had been purple and bruise-like for several years but turned a near black color 1 month ago. He reported no discoloration of his sweat or urine. He had no history of malnutrition and reported infrequent alcohol use.

Please finish quiz first before checking answer.

You answered correctly!

Read the answer below and download your certificate.

You answered incorrectly.

Read the discussion below and retake the quiz.

A 69-year-old man presented with a 1-month history of progressive skin discoloration. His medical history included chronic kidney disease, chronic hepatitis C infection, cirrhosis, ischemic cardiomyopathy with an implantable cardioverter-defibrillator (ICD), and atrial fibrillation with prophylactic apixaban. He had recurrent staphylococcus bacteremia due to infection of an ICD lead and had been treated for the past 6 months with minocycline, 100 mg twice daily. His arms had been purple and bruise-like for several years but turned a near black color 1 month ago. He reported no discoloration of his sweat or urine. He had no history of malnutrition and reported infrequent alcohol use.

Survey Complete!

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Misha Rosenbach, MD, Department of Dermatology, University of Pennsylvania, 3600 Spruce St, 2 Maloney, Philadelphia, PA 19104 (Misha.Rosenbach@pennmedicine.upenn.edu).

Conflict of Interest Disclosures: None reported.

Additional Contributions: We thank David E. Elder, MBChB (University of Pennsylvania Perelman School of Medicine) for his work in evaluating the biopsy and highlighting histopathologic features important for determining this patient’s diagnosis. We thank the patient for granting permission to publish this information.

References
1.
Lorente  M , Ballano  A , Juanes  A , Pastor  MA , Cuevas  J .  Blue-gray pigmentation in trunk and extremities in a 71-year-old man.   JAMA Dermatol. 2013;149(9):1111-1112. doi:10.1001/jamadermatol.2013.4365PubMedGoogle ScholarCrossref
2.
Bolognia  JL , Schaffer  JV , Cerroni  L . Dermatology. Elsevier; 2017.
3.
Kowdley  KV , Brown  KE , Ahn  J , Sundaram  V .  ACG Clinical Guideline: hereditary hemochromatosis.   Am J Gastroenterol. 2019;114(8):1202-1218. doi:10.14309/ajg.0000000000000315PubMedGoogle ScholarCrossref
4.
Dwyer  CM , Cuddihy  AM , Kerr  REI , Chapman  RS , Allam  BF .  Skin pigmentation due to minocycline treatment of facial dermatoses.   Br J Dermatol. 1993;129(2):158-162. doi:10.1111/j.1365-2133.1993.tb03519.xPubMedGoogle ScholarCrossref
5.
Hanada  Y , Berbari  EF , Steckelberg  JM .  Minocycline-induced cutaneous hyperpigmentation in an orthopedic patient population.   open forum infect dis. 2016;3(1):ofv107. doi:10.1093/ofid/ofv107PubMedGoogle Scholar
6.
Roberts  G , Capell  HA .  The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population.   J Rheumatol. 2006;33(7):1254-1257.PubMedGoogle Scholar
7.
Okada  N , Sato  S , Sasou  T , Aoyama  M , Nishida  K , Yoshikawa  K .  Characterization of pigmented granules in minocycline-induced cutaneous pigmentation: observations using fluorescence microscopy and high-performance liquid chromatography.   Br J Dermatol. 1993;129(4):403-407. doi:10.1111/j.1365-2133.1993.tb03166.xPubMedGoogle ScholarCrossref
8.
Argenyi  ZB , Finelli  L , Bergfeld  WF ,  et al.  Minocycline-related cutaneous hyperpigmentation as demonstrated by light microscopy, electron microscopy and X-ray energy spectroscopy.   J Cutan Pathol. 1987;14(3):176-180. doi:10.1111/j.1600-0560.1987.tb00493.xPubMedGoogle ScholarCrossref
9.
Nakamura  S , Yokozeki  H , Nishioka  K .  Acute pigmentation due to minocycline therapy in atopic dermatitis.   Br J Dermatol. 2003;148(5):1073-1074. doi:10.1046/j.1365-2133.2003.05271.xPubMedGoogle ScholarCrossref
10.
Green  D , Friedman  KJ .  Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature.   J Am Acad Dermatol. 2001;44(2)(suppl):342-347. doi:10.1067/mjd.2001.103036PubMedGoogle ScholarCrossref
AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
  • 1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
  • 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
  • 1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
  • 1.00 credit toward the CME [and Self-Assessment requirements] of the American Board of Surgery’s Continuous Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close